The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.
The drug is made from purified cannabidiol, or CBD, a compound found in the cannabis plant. The drug will be marketed under the brand name Epidiolex. Read More
Most people understand that cannabis is responsible for producing cannabinoids; most notably delta-9 THC and CBD. What many people don’t fully understand is that cannabis produces other phytochemicals (chemicals produced by plants) that are therapeutically active. Terpenes are a class of phytochemicals produced by cannabis (and other plants), and in fact scientists believe that terpenes serve as the building blocks for cannabinoids in the cannabis plant. That being said, terpenes in and of themselves are considered to be therapeutically relevant in many ways. Read More
The opponents to State Question 788 are treating Oklahomans as if we are idiots.
Pawnee County Sheriff Mike Waters is telling us that if the proposal passes, “an 18-year-old can go to a veterinarian, say he gets headaches, and then be given a two-year license to carry enough marijuana for 85 joints.” I do not know what he was reading, but Section 1, Paragraph M of SQ 788, says that applications must be approved by “an Oklahoma Board certified physician.” Don’t let Sheriff Waters lie to you. Read More
Marijuana is recreationally legal in California but still carries an “only for stoners” stigma in some circles. Maybe not for long.On a recent Friday night, Twin Peaks real estate agent Shelly Sutherland invited two dozen friends for a happy hour featuring alcohol-free cocktails laced with pomegranate seeds and cannabis-infused tea — not to get high, but to get highly educated about cannabis and its potential for health, wellness and, yes, even the giggles. Read More
Researchers reported that the enactment of both medicalization and adult-use laws were both associated with reductions in opioid prescribing rates, with broader legalization policies associated with the greatest rates of decline. Read More
In a recent survey of medical marijuana users, 76 percent of respondents reported using cannabis for relaxation and 65 percent as a sleep aid. The survey, conducted by HelloMD—the “largest community of patients using marijuana for health and wellness in the country”—also found that comorbid, insomnia-inducing factors were also popular reasons for weed intake: stress and depression. As many as 84 percent respondents reported that the mind-altering, psychoactive drug provides them with a significant relief of symptoms, and 96 percent of users said they’d recommend marijuana to their friends. Read More
More than two-thirds of self-identified Democrats, Republicans, and Independents are in favor of medical cannabis legalization, according to nationwide survey data compiled by the polling firm Fabrizio, Lee, and Associates. Read More
Investigators at the University of Oregon compared traffic accident outcomes in Colorado and Washington following legalization to those in other states with similar pre-legalization economic and traffic trends. They reported, "We find that states that legalized marijuana have not experienced significantly different rates of marijuana- or alcohol-related traffic fatalities relative to their synthetic controls." Read More